The Efficacy and Safety of HIPEC Combined With PD-1 and SOX Chemotherapy for the Translational Treatment of GC or EGJC With PM

NCT06427252 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer, Metastatic

Interventions

DRUG: HIPEC
DRUG: Systemic therapy

Sponsor

The First Affiliated Hospital with Nanjing Medical University